Cameco (NYSE: CCJ) received a number of price target changes and ratings updates during the last week:

  • Cameco had its price target lowered by analysts at Raymond James from $28.00 to $26.00. They now have an “outperform” rating on the stock.
  • Cameco had its price target lowered by analysts at BMO Capital Markets from $29.00 to $25.00. They now have an “outperform” rating on the stock.
  • Cameco had its price target lowered by analysts at TD Securities from $24.00 to $22.00. They now have a “hold” rating on the stock.
  • Cameco had its price target lowered by analysts at Desjardins Securities from $32.65 to $26.50. They now have a “buy” rating on the stock.
  • Cameco had its price target lowered by analysts at UBS AG from $26.00 to $24.00. They now have a “buy” rating on the stock.
  • Cameco had its price target lowered by analysts at Bank of America to $23.00. They wrote, “We lowered our Cameco Corp. (CCO) price objective (PO) C$1/share to C$23, following very weak 3Q12 operating results (low uranium sales). However, we maintained a Buy rating on CCO as near term uncertainty on uranium demand is outweighed by improved fundamentals medium term (12 mos). The lower PO was driven by 5% and 1% lower 2013 EBITDA and EPS (on higher cash costs, offset by lower effective tax rate), plus a lower NAV as we incorporate McArthur River and Key Lake increased capex (offset by higher production, lower cash costs).”

Shares of Cameco Co. traded up 1.15% during mid-day trading on Tuesday, hitting $18.53. Cameco Co. has a 52 week low of $16.59 and a 52 week high of $26.45. The company has a market cap of $7.216 billion and a P/E ratio of 14.62.

Cameco Corporation (Cameco) is engaged in the exploration for and the development, mining, refining, conversion and fabrication of uranium for sale as fuel for generating electricity in nuclear power reactors in Canada and other countries.